Volume 119, Issue 5 , Pages 1072-1078, May 2007
The variability of regional airflow obstruction within the lungs of patients with asthma: Assessment with hyperpolarized helium-3 magnetic resonance imaging
Background
It is unknown whether focal changes of airflow obstruction within the lungs of patients with asthma vary or are fixed in location with time or repeated bronchoconstriction. With hyperpolarized helium-3 magnetic resonance (H3HeMR) imaging, the airspaces are depicted and focal areas of airflow obstruction are shown as “ventilation defects.”
Objective
To investigate the regional changes of airflow obstruction with time and repeated bronchoconstriction.
Methods
H3HeMR and spirometry were performed before (pre) and immediately after (post) methacholine challenge in 10 young patients with asthma on 2 days that were 7-476 days (mean, 185.3 ± 37.2 days) apart. Pair-wise image comparisons were performed to determine the change in location of ventilation defects within the lung and their change in size.
Results
When comparing premethacholine versus premethacholine and postmethacholine versus post-methacholine images of the 2 days, 41% ± 10% and 69% ± 5% (P = .017) of defects, respectively, were in the same location, and of those, 69% ± 12% and 43% ± 5% (P = .022), respectively, did not change size. Comparing premethacholine versus postmethacholine images, 58% ± 9% of defects were in the same location on day 1 and 73% ± 7% (P = .088) on day 2. On both days, the percent increase in defect number from premethacholine to postmethacholine was much greater than the percent decrease in spirometric values (P < .001).
Conclusion
Many of the ventilation defects persisted or recurred in the same location with time or repeated bronchoconstriction, suggesting that the regional changes of airflow obstruction are relatively fixed within the lung.
Clinical implications
The findings give new insight into the regional airflow variability within the lungs of patients with asthma.
Key words: Airflow obstruction, airway, asthma, bronchial activity, hyperpolarized gases, hyperpolarized helium-3, pulmonary function, spirometry, magnetic resonance imaging, MRI, ventilation defect, ventilation, lung diseases
Abbreviations used: FEF25-75, Forced expiratory flow at 25% to 75% of forced vital capacity, FVC, Forced vital capacity, H3He, Hyperpolarized helium-3, H3HeMR, Hyperpolarized helium-3 magnetic resonance, MCT, Methacholine challenge test, MRI, Magnetic resonance imaging, NAEPP, National Asthma Education and Prevention Program of the National Institutes of Health, VDS, Number of ventilation defects per slice
Supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health (grant RO1 HL 66479), the Commonwealth of Virginia Technology Research Fund (grant IN2002-01), and Siemens Medical Solutions.Disclosure of potential conflict of interest: J. R. Brookeman and J. P Mugler have received grant support from Siemens Medical Solutions. The rest of the authors have declared that they have no conflict of interest.
PII: S0091-6749(07)00161-3
doi:10.1016/j.jaci.2006.12.659
© 2007 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Volume 119, Issue 5 , Pages 1072-1078, May 2007
